IT infrastructure and business process services firm Cognizant has
announced an alliance with CTC Laboratory Systems that aims to
assist Japanese pharmaceutical firms in enhancing efficiencies in
drug discovery and development.
Analytical equipment specialists Waters made a solid start to 2008,
posting a 12 per cent increase in first-quarter revenues buoyed on
by higher margin expansions and strong global sales that build on
previous quarterly performances.
US firms Sepragen and Neugenesis are teaming up to develop a
high-throughput platform for monoclonal antibody and influenza
vaccine production that is rapid, scalable and flexible enough to
respond to a potential pandemic.
The problems facing companies trying to bring 'biosimilar' versions
of biologic drugs to market were thrown into stark relief yesterday
when the US Food and Drug Administration (FDA) refused to approve
Genzyme's genetic...
US drug giant Pfizer plans to close or sell off an additional 13
manufacturing facilities as part of an effort to cut its number of
production plants to 44 by the end of 2009.
Chiltern has become the latest in a growing number of contract
research organisations (CROs) to establish a foothold within the
clinical sleeping giant that is Russia.
Germany-based Gene Bridges has licensed its Red/ET Recombineering
technology to Novozymes for genetically engineering recombinant
micro-organisms for use in industrial applications.
The US Food and Drug Administration (FDA) has revealed it will be
operating on the ground in China imminently, while the Drug
Information Association (DIA) has just planted itself in Asia's
other pharma don, India.
You'll be unlikely to see them at your local cinema, but molecular
animations created using highly accurate information from X-ray
scattering images, will help explain how proteins and organic
molecules behave in a solution.
GEA Pharma Systems' Collette unit will present Consigma, its new
continuous high shear granulation and drying system, at the
Interpack exhibition in Düsseldorf later this month.
Frank Torti has been appointed to the newly created post of chief
scientist at the FDA, with a brief to "oversee, coordinate, and
ensure quality and regulatory focus of the intramural research
programs".
The contract manufacturing organisation (CMO) business model needs
to change if companies expect to remain competitive in this
evolving industry, which is tipped to see tough times ahead.
Eli Lilly plans to cut 500 jobs, mainly in manufacturing, as it
attempts to restructure its operations to mitigate against the
losses from inhaled insulin.
An $8.8m collaboration between two pharma companies and a leading
university has resulted in a project that uses fragment-based
crystallography and in silico fragment screening for lead
identification.
Febit has updated its Geniom microRNA analysis platform with the
latest version of the Sanger Institute's database of all known
miRNA elements. The upgrade should provide scientists with a more
detailed microRNA profile of their...
The US Food and Drug Administration (FDA) believes that the
contamination of Baxter's blood thinner heparin, which has been
linked to 62 deaths in the US, may have been due to the deliberate
replacement of some ingredients with...
Pharmaceutical firms operating in Canada could face increasing
regulatory pressure if government plans to tighten up consumer
protection laws are passed.
New data from an early-stage trial of Vectura's inhaled migraine
candidate VR147 suggest that it could offer significant advantages
over currently-available treatments.
The proposed split of the Celera Group from its parent Applera
Corporation to form a separate, publicly-traded company is
gathering momentum with a preliminary prospectus now filed with the
US Securities and Exchange Commission.
Buckyballs have the annoying tendency of sticking together in
floating clumps in water - a property that prevents them from
settling to be removed from waste water from industrial production.
LabTechnologist.com presents a round-up of new products that have
been introduced to the laboratory equipment market of late,
including items from Matrical, Millrock Technology, AnaSpec, Lab M
and ibidi.
At present India appears to be beating China in the race for Asia's
top clinical spot, according to new figures published by india´s
Planning Commission.
Overall, 2007 was another stellar year for contract service
providers, particularly those at the early-stage end of
development, although companies are advised to watch out for a
tougher environment ahead.
The number of people whose deaths are associated with an allergic
reaction to heparin has shot up as the US Food and Drug
Administration (FDA) has updated its tally.
United Drug has just purchased two UK services firms for a sum of
£14.4m, in a continuation of what has been a highly-acquisitive
past year for the ambitious firm.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving CRI Worldwide,
Pacific Biometrics, Encorium Group and Cato research.
GlaxoSmithKline has opted not to sign an exclusive development
agreement with UK sexual health specialist Futura Health for its
transdermal pain relief product, TPR100.
Pfizer has updated the US product labeling of its inhaled insulin
treatment Exubera to include a warning of increased risk of lung
cancer among those using it.
Actavis has purchased a 90 per cent stake in Zhejiang Chiral
Medicine Chemicals (CMC), a Hangzhou, China-based active
pharmaceutical ingredients (API) maker.
BioFocus DPI, a subsidiary of Galapagos, has launched a new
platform for drug discovery at the Society for Biomolecular
Sciences Annual Conference taking place this week in St Louis.
Cephalon has licensed the hydrophobic drug delivery system (HDDS)
and a reformulated version of paclitaxel, called AI-850, from
Acusphere in a $10m deal.
PPD, INC Research, Parexel, Cato Research, Pacific Biomarkers and
Discovery Laboratories have all had people on the move in the world
of pharmaceutical outsourcing.
Stiefel Laboratories, Biopharm Services, Multisorb Technologies,
the Pharmaceutical Research and Manufacturers of America, Catalent
Pharma Solutions and Chromatide have all had people on the
move in the world of pharmaceutical manufacturing.
Two products aimed at enhancing the efficiency of process
development in biopharmaceutical manufacturing are the latest
offerings from GE Healthcare, the UK-based medical technology and
services company.
US-based Delcath Systems has achieved positive results in treating
diffuse liver cancer using its percutaneous hepatic perfusion (PHP)
delivery system.
US demand for drug delivery systems is set to increase by over 10
per cent a year, reaching $132bn in 2012 with growth driven by
injectable biologic dugs, according to a new study by the Freedonia
Group.
Olympus is planning to expand its European operations with a €15m
R&D centre in Munich, Germany, tasked with producing the next
generation of in vitro lab diagnostics and laboratory
automation equipment.
Zogenix says that proceeds from a planned $86m initial public
offering (IPO) will be used to fund development of its pipeline of
needle-free medicines for pain and central nervous system
indications.